STAT+: Pharmalittle: We’re reading about an FDA commissioner candidate, Germany’s plans for drug prices, and more
Why this matters: health reporting relevant to everyday decisions and well-being.
Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we celebrate this notion with a cup or three of delicious stimulation. Our choice today is pistachio. As always, you are welcome to join us. Meanwhile, we have assembled the latest menu of tidbits to help you along. So please dig in. Have a smashing day and please feel free to forward any secrets you come across. Our “in basket” is always open.… White House policy aide Heidi Overton is among the final candidates being considered by the Trump administration to lead the U.S. Food and Drug Administration, Bloomberg News reports. No final decision has been made, though, and it is unclear whether Overton has the support of U.S. Health and Human Services Secretary Robert F. Kennedy Jr. Overton is a deputy assistant to the president for domestic policy at the White House working on health issues. She previously worked at the think tank America First Policy Institute. Overton is a medical doctor and has a doctorate in clinical investigation from Johns Hopkins University. She also was a White House fellow in the first Trump administration. Eli Lilly expects to launch its weight loss pill in Europe and the U.K. in the second half of 2026 or early ​2027, with the drugmaker targeting the out-of-pocket telehealth market as it ‌has done in the United States, Reuters says. Lilly still plans to pursue public reimbursement from European governments where possible, even as new U.S. drug pricing policies complicate negotiations with health authorities. And the company will do so in ways that are consistent with its interpretation of the Trump administration’s “most-favored nation” framework, which links prices to U.S. net prices ⁠adjusted ​for countries’